GeneDx Stock Quote WGS - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

62.01

Bid

62.01

Ask

65.00

Volume

491,729

63.475 Day's Range 65.91

24.91 52 Week Range 117.75

Market Cap

1.769B

Previous Close

66.37

Open

64.68

Last Trade

188

62.01

(formt)

Last Trade Time

Financial Volume

$ 31,886,815

VWAP

64.8463

Average Volume (3m)

1,131,101

Shares Outstanding

28,533,204

Dividend Yield

PE Ratio

-35.23

Earnings Per Share (EPS)

-1.83

Revenue

305.45M

Net Profit

-52.29M

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and... GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut. Show more

Sector

Blank Checks

Industry

Health Services

Website

www.genedx.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

GeneDx Holdings Corporation is listed in the Blank Checks sector of the NASDAQ with ticker WGS. The last closing price for GeneDx was $66.37. Over the last year, GeneDx shares have traded in a share price range of $ 24.91 to $ 117.75.

GeneDx currently has 28,533,204 shares outstanding. The market capitalization of GeneDx is $1.89 billion. GeneDx has a price to earnings ratio (PE ratio) of -35.23.

Overall Flow

Bearish

Net Premium

-283k

Calls / Puts

83.33%

Buys / Sells

233.33%

OTM / ITM

37.50%

Sweeps Ratio

0.00%

INVESTIGATION ALERT: Edelson Lechtzin LLP is investigating GeneDx Holdings Corp. (NASDAQ: WGS) and Encourages Investors with Substantial Losses to Contact the Firm

INVESTIGATION ALERT: Edelson Lechtzin LLP is investigating GeneDx Holdings Corp. (NASDAQ: WGS) and Encourages...

GeneDx to Participate in Upcoming Investor Conferences

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will...

GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale

Company deploying AI to scale industry-leading rare disease dataset to diagnose growing number of patients with genetic disease, published in the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-8.57	-12.1422499292	70.58	74.445	62.01	751181	69.364133	CS
4	-2.89	-4.4530046225	64.9	76.205	62.01	787687	70.07396282	CS
12	-32.5	-34.3878954608	94.51	117.75	55.17	1131101	76.40861033	CS
26	-11.6	-15.7587284336	73.61	117.75	55.17	1047911	80.60134562	CS
52	34.73	127.309384164	27.28	117.75	24.91	774118	70.84019135	CS
156	51.087	467.701180994	10.923	117.75	1.16	970647	31.47874123	CS
260	51.087	467.701180994	10.923	117.75	1.16	970647	31.47874123	CS

WGS - Frequently Asked Questions (FAQ)

What is the current GeneDx share price?

The current share price of GeneDx is $ 62.01

How many GeneDx shares are in issue?

GeneDx has 28,533,204 shares in issue

What is the market cap of GeneDx?

The market capitalisation of GeneDx is USD 1.89B

What is the 1 year trading range for GeneDx share price?

GeneDx has traded in the range of $ 24.91 to $ 117.75 during the past year

What is the PE ratio of GeneDx?

The price to earnings ratio of GeneDx is -35.23

What is the cash to sales ratio of GeneDx?

The cash to sales ratio of GeneDx is 6.03

What is the reporting currency for GeneDx?

GeneDx reports financial results in USD

What is the latest annual turnover for GeneDx?

The latest annual turnover of GeneDx is USD 305.45M

What is the latest annual profit for GeneDx?

The latest annual profit of GeneDx is USD -52.29M

What is the registered address of GeneDx?

The registered address for GeneDx is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the GeneDx website address?

The website address for GeneDx is www.genedx.com

Which industry sector does GeneDx operate in?

GeneDx operates in the HEALTH SERVICES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RBNERobin Energy Ltd	$ 13.85 (313.43%)	101.81M
OPOceanPal Inc	$ 1.63 (125.45%)	80.28M
LGHLWLion Group Holding Ltd	$ 0.0052 (116.67%)	6.87M
NEONNeonode Inc	$ 16.83 (68.47%)	4.78M
ICONIcon Energy Corporation	$ 2.90 (62.01%)	59.04M
SBETSharpLink Gaming Inc	$ 9.2275 (-71.63%)	41.92M
AIHSSenmiao Technology Ltd	$ 0.381 (-63.01%)	16.8M
CHSNChanson International Holding	$ 0.22 (-60.00%)	15.15M
KWMK Wave Media Ltd	$ 2.91 (-50.43%)	2.59M
JZXNJiuzi Holdings Inc	$ 1.56 (-46.39%)	2.24M
HCTIHealthcare Triangle Inc	$ 0.0201 (-33.00%)	856.89M
GNLNGreenlane Holdings Inc	$ 0.0101 (-34.42%)	792.34M
CGBSCrown LNG Holdings Ltd	$ 0.1104 (31.43%)	788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 12.655 (3.81%)	246.13M
NVDANVIDIA Corporation	$ 141.97 (-2.09%)	180.81M